Trial Profile
Long-term clinical outcomes of antiplatelet therapy discontinuation and stent thrombosis in patients undergoing sirolimus-eluting stent implantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Aspirin; Clopidogrel; Ticlopidine
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions
- 12 Jul 2016 New trial record